These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15369246)

  • 21. [Malignant ovarian germ cell tumours: a trial of 36 cases].
    Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
    Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Risk factors for recurrent disease in borderline ovarian tumors].
    Líbalová P; Vernerová Z; Hubicková-Heringová L; Pintérová D; Tikovský K; Kubecová M; Svoboda B
    Ceska Gynekol; 2012 Feb; 77(1):31-5. PubMed ID: 22536638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
    Anfinan N; Sait K; Ghatage P; Nation J; Chu P
    Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy.
    Signorelli M; Fruscio R; Ceppi L; Dell'anna T; Vitobello D; Chiappa V; Siesto G; Milani R; Landoni F; Mangioni C
    Gynecol Oncol; 2014 Feb; 132(2):312-5. PubMed ID: 24423881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence and prognostic factors in borderline ovarian tumors.
    Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
    Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelial ovarian tumors of borderline malignancy: long-term follow-up.
    Casey AC; Bell DA; Lage JM; Fuller AF; Nikrui N; Rice LW
    Gynecol Oncol; 1993 Sep; 50(3):316-22. PubMed ID: 8406194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Borderline ovarian tumors: features and controversial aspects.
    Messalli EM; Grauso F; Balbi G; Napolitano A; Seguino E; Torella M
    Eur J Obstet Gynecol Reprod Biol; 2013 Mar; 167(1):86-9. PubMed ID: 23219291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Granulosa cell tumor--clinical group and literature review].
    Freitag P; Janousek M; Jancárková N; Bendová M; Strunová M; Zivný J
    Ceska Gynekol; 2000 May; 65(3):163-6. PubMed ID: 10953492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
    Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
    Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unexpected ovarian malignancy following laparoscopic excision of adnexal masses.
    Matsushita H; Watanabe K; Yokoi T; Wakatsuki A
    Hum Reprod; 2014 Sep; 29(9):1912-7. PubMed ID: 24964925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants.
    Leary A; Petrella MC; Pautier P; Duvillard P; Uzan C; Tazi Y; Ledoux F; Gouy S; Morice P; Lhommé C
    Gynecol Oncol; 2014 Jan; 132(1):23-7. PubMed ID: 24219980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucinous tumor of low malignant potential ("borderline" or "atypical proliferative" tumor) of the ovary: a study of 171 cases with the assessment of intraepithelial carcinoma and microinvasion.
    Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Siriaunkgul S
    Int J Gynecol Pathol; 2011 May; 30(3):218-30. PubMed ID: 21464732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9).
    Mangili G; Scarfone G; Gadducci A; Sigismondi C; Ferrandina G; Scibilia G; Viganò R; Tateo S; Villa A; Lorusso D
    Gynecol Oncol; 2010 Oct; 119(1):48-52. PubMed ID: 20599258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of 21 cases of epithelial ovarian malignancies in women aged below 30 years].
    Chen R; Shen K; Wu M; Pan LY; Huang HF; Yang JX; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jun; 40(6):417-20. PubMed ID: 16008896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Borderline tumors of the ovary.
    Damak T; Ben Hassouna J; Chargui R; Gamoudi A; Hechiche M; Dhieb T; Rahal K
    Tunis Med; 2014 Jun; 92(6):411-6. PubMed ID: 25741843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
    Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frozen section in borderline ovarian tumors: is it reliable?
    Ureyen I; Turan T; Cirik DA; Tasci T; Boran N; Bulbul D; Tulunay G
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():115-8. PubMed ID: 25145763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Borderline tumors : diagnosis and management : report of 10 cases].
    Souki DZ; Bouchahda H; Limem W; Mahjoub S; Zakraoui MA; Ben Hmid R; Zouari F
    Tunis Med; 2010 May; 88(5):312-6. PubMed ID: 20517826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
    Suh-Burgmann E
    Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.